- Home
- INKT vs AIOS Comparison
INKT vs AIOS Comparison
Compare INKT & AIOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INKT | AIOS |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | China |
| Employees | N/A | 20 |
| Industry | Medicinal Chemicals and Botanical Products | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 42.8M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | INKT | AIOS |
|---|---|---|
| Price | $11.98 | $13.57 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 6.9K | ★ 20.6K |
| Earning Date | 05-15-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.48 | $0.39 |
| 52 Week High | $16.80 | $33.87 |
Technical Indicators
Market Signals| Indicator | INKT | AIOS |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 53.64 |
| Support Level | $10.76 | $13.01 |
| Resistance Level | $12.20 | $16.24 |
| Average True Range (ATR) | 0.69 | 1.43 |
| MACD | 0.12 | 0.25 |
| Stochastic Oscillator | 98.89 | 53.23 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About AIOS AIOS Tech Inc. Class A Common Shares
AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.